Danish medtech company Neurescue has gained a European CE mark for its catheter to address non-shockable cardiac arrest.

The company’s catheter is used in conjunction with a handheld control unit to temporarily inflate a soft balloon via the femoral artery into the descending aorta to promote the redirection of blood flow towards the heart and brain during cardiopulmonary resuscitation (CPR).

According to Neurescue, the technique, known as aortic balloon occlusion (ABO), serves to boost central blood flow within one minute of deployment to restore a heartbeat in cardiac arrest patients, thereby carving out ‘bridging’ time to get patients access to ventricular assist or coronary interventional therapies.